multimericbio.com - Multimeric Biotherapeutics – FortiVac Vaccine Platform Technology

home > domains > multimericbio.com

Description: FortiVac Vaccine Platform Technology

vaccine (299) hiv vaccine (10) cancer vaccine (7) cd40l (2) cd8+ t cell (2) sars-cov-2 vaccine (2) prostate cancer vaccine (2)

Example domain paragraphs

Multimeric Biotherapeutics

FortiVac Vaccine Platform Technology

FortiVac uses CD40 ligand (CD40L) to activate dendritic cells and simultaneously pulse them with antigen. This is done using a patented fusion protein of CD40L, antigen, and a multimerization scaffold taken from surfactant protein D (SPD) = FortiVac. The result is an extraordinary activation of CD8+ “killer” T cell responses.

Links to multimericbio.com (1)

• multimericbiotherapeutics.com Multimeric Biotherapeutics – FortiVac Vaccine Platform Technology